CD19 ANTIGEN LOSS

CD19 ANTIGEN LOSS was reported 16 times

CD19 ANTIGEN LOSS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1 0.0002
1 CD19-directed Chimeric Antigen Receptor [EPC] 1 0.0001
2 Pyrimidine Synthesis Inhibitor [EPC] 2 0.0000
3 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1 0.0000
4 Rifamycin Antibacterial [EPC] 1 0.0000
5 CD20-directed Cytolytic Antibody [EPC] 4 0.0000
6 Interferon beta [EPC] 2 0.0000
7 Alkylating Drug [EPC] 1 0.0000
8 Thalidomide Analog [EPC] 2 0.0000
9 Kinase Inhibitor [EPC] 1 0.0000
10 Corticosteroid [EPC] 1 0.0000